ICH Q1F Region-Specific Expectations for Long-Term Stability Testing
ICH Q1F was introduced to extend the scope of ICH Q1A(R2) by providing storage condition guidance tailored to different climatic zones:
Click to read the full article.
ICH Q1F was introduced to extend the scope of ICH Q1A(R2) by providing storage condition guidance tailored to different climatic zones:
Click to read the full article.
Stability data reporting serves several critical objectives:
Click to read the full article.
New impurities are degradation products that appear over time during real-time storage but were not previously identified during forced degradation or accelerated studies.
Click to read the full article.
Stability chambers simulate real-time and accelerated environmental conditions required under ICH Q1A(R2). If the chamber fails to maintain temperature or relative humidity within specified ranges, the data generated may be invalid, leading to regulatory non-compliance, product recall, or data rejection during submission.
Click to read the full article.
Accelerated data can be predictive if the degradation mechanism remains the same and the kinetics are consistent with the Arrhenius equation.
Click to read the full article.
Unlike small molecules, biologics are:
Click to read the full article.
Climatic zones are classifications used to group countries and regions based on temperature and humidity patterns. These classifications help determine the appropriate long-term storage conditions under which stability testing should be conducted.
Click to read the full article.
Discrepancies occur when trends observed in accelerated stability studies do not align with those observed during real-time long-term studies. These can manifest as:
Click to read the full article.
Matrixing is a statistical design approach where only a selected subset of the total number of possible samples is tested at each scheduled time point. The full set of combinations is still tested over the course of the study, but each specific sample is tested at fewer time points.
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.
